Found: 50
Select item for more details and to access through your institution.
A streamlined failure mode and effects analysis.
- Published in:
- Medical Physics, 2014, v. 41, n. 6, p. 1, doi. 10.1118/1.4875687
- By:
- Publication type:
- Article
The International Cancer Expert Corps: a unique approach for sustainable cancer care in low and lower-middle income countries.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00333
- By:
- Publication type:
- Article
Molecularly Targeted Agents as Radiosensitizers in Cancer Therapy--Focus on Prostate Cancer.
- Published in:
- International Journal of Molecular Sciences, 2013, v. 14, n. 7, p. 14800, doi. 10.3390/ijms140714800
- By:
- Publication type:
- Article
A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts.
- Published in:
- 2011
- By:
- Publication type:
- journal article
A functional screen identifies miRNAs that inhibit DNA repair and sensitize prostate cancer cells to ionizing radiation.
- Published in:
- Nucleic Acids Research, 2015, v. 43, n. 8, p. 4075, doi. 10.1093/nar/gkv273
- By:
- Publication type:
- Article
A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Adoption of an incident learning system in a regionally expanding academic radiation oncology department.
- Published in:
- Reports of Practical Oncology & Radiotherapy, 2019, v. 24, n. 4, p. 338, doi. 10.1016/j.rpor.2019.05.008
- By:
- Publication type:
- Article
Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor.
- Published in:
- PLoS ONE, 2010, v. 5, n. 6, p. 1, doi. 10.1371/journal.pone.0011208
- By:
- Publication type:
- Article
Induction of double-strand breaks with the non-steroidal androgen receptor ligand flutamide in patients on androgen suppression: a study protocol for a randomized, double-blind prospective trial.
- Published in:
- Trials, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s13063-023-07838-4
- By:
- Publication type:
- Article
Absorbable hydrogel spacer use in men undergoing prostate cancer radiotherapy: 12 month toxicity and proctoscopy results of a prospective multicenter phase II trial.
- Published in:
- Radiation Oncology, 2014, v. 9, n. 1, p. 1, doi. 10.1186/1748-717X-9-96
- By:
- Publication type:
- Article
Absorbable hydrogel spacer use in men undergoing prostate cancer radiotherapy: 12 month toxicity and proctoscopy results of a prospective multicenter phase II trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Metastasis-Directed Therapy In Prostate Cancer: Why, When, and How?
- Published in:
- Oncology (08909091), 2019, v. 33, n. 10, p. 394
- By:
- Publication type:
- Article
Stereotactic Radiation Therapy Combined With Immunotherapy: Augmenting the Role of Radiation in Local and Systemic Treatment.
- Published in:
- Oncology (08909091), 2015, v. 29, n. 5, p. 331
- By:
- Publication type:
- Article
(S025) Discovery and Validation of Predictive Factors for Safety Incident Reports in Patients Receiving Radiation Therapy: Comparative Results From a Large Safety Variance Database.
- Published in:
- Oncology (08909091), 2015, v. 29, p. 1
- By:
- Publication type:
- Article
Evaluating Advanced Technologies in Radiation Oncology: When and How Should Randomized Trials Be Done?
- Published in:
- Oncology (08909091), 2009, v. 23, n. 4, p. 390
- By:
- Publication type:
- Article
Preneoplastic Prostate Lesions.
- Published in:
- Annals of the New York Academy of Sciences, 2001, v. 952, n. 1, p. 135, doi. 10.1111/j.1749-6632.2001.tb02734.x
- By:
- Publication type:
- Article
Pathological and molecular mechanisms of prostate carcinogenesis: Implications for diagnosis, detection, prevention, and treatment.
- Published in:
- Journal of Cellular Biochemistry, 2004, v. 91, n. 3, p. 459, doi. 10.1002/jcb.10747
- By:
- Publication type:
- Article
Stereotactic ablative radiation therapy for oligometastatic prostate cancer delays time-to-next systemic treatment.
- Published in:
- World Journal of Urology, 2019, v. 37, n. 12, p. 2623, doi. 10.1007/s00345-018-2477-2
- By:
- Publication type:
- Article
Novel therapeutic strategies in prostate cancer management using gene therapy in combination with radiation therapy.
- Published in:
- World Journal of Urology, 2003, v. 21, n. 4, p. 275, doi. 10.1007/s00345-003-0363-y
- By:
- Publication type:
- Article
The life and death of DNA-PK.
- Published in:
- Oncogene, 2005, v. 24, n. 6, p. 949, doi. 10.1038/sj.onc.1208332
- By:
- Publication type:
- Article
Adjuvant Radiotherapy After Surgery for Prostate Cancer.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Prostate Cancer-Specific Survival Following Salvage Radiotherapy vs Observation in Men With Biochemical Recurrence After Radical Prostatectomy.
- Published in:
- JAMA: Journal of the American Medical Association, 2008, v. 299, n. 23, p. 2760, doi. 10.1001/jama.299.23.2760
- By:
- Publication type:
- Article
Hyperthermic biology and cancer therapies: a hypothesis for the "Lance Armstrong effect".
- Published in:
- 2006
- By:
- Publication type:
- journal article
Hyperthermic Biology and Cancer Therapies.
- Published in:
- JAMA: Journal of the American Medical Association, 2006, v. 296, n. 4, p. 445, doi. 10.1001/jama.296.4.445
- By:
- Publication type:
- Article
Radiation Dose Escalation as Treatment for Clinically Localized Prostate Cancer: Is More Really Better?
- Published in:
- 2005
- By:
- Publication type:
- Editorial
Radiation Therapy and Androgen Suppression as Treatment for Clinically Localized Prostate Cancer: The New Standard?
- Published in:
- JAMA: Journal of the American Medical Association, 2004, v. 292, n. 7, p. 864, doi. 10.1001/jama.292.7.864
- By:
- Publication type:
- Article
Nuclear morphometry predicts disease-free interval for clinically localized adenocarcinoma of the prostate treated with definitive radiation therapy.
- Published in:
- International Journal of Cancer, 1999, v. 84, n. 6, p. 594, doi. 10.1002/(SICI)1097-0215(19991222)84:6<594::AID-IJC9>3.0.CO;2-D
- By:
- Publication type:
- Article
A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Impact of radiation dose on recurrence in high‐risk prostate cancer patients.
- Published in:
- Prostate, 2020, v. 80, n. 15, p. 1322, doi. 10.1002/pros.24059
- By:
- Publication type:
- Article
Detectable end of radiation prostate specific antigen assists in identifying men with unfavorable intermediate‐risk prostate cancer at high risk of distant recurrence and cancer‐specific mortality.
- Published in:
- Prostate, 2018, v. 78, n. 8, p. 623, doi. 10.1002/pros.23507
- By:
- Publication type:
- Article
GSTP1 Loss Results in Accumulation of Oxidative DNA Base Damage and Promotes Prostate Cancer Cell Survival Following Exposure to Protracted Oxidative Stress.
- Published in:
- Prostate, 2016, v. 76, n. 2, p. 199, doi. 10.1002/pros.23111
- By:
- Publication type:
- Article
Androgen withdrawal fails to induce detectable tissue hypoxia in the rat prostate.
- Published in:
- Prostate, 2014, v. 74, n. 8, p. 805, doi. 10.1002/pros.22803
- By:
- Publication type:
- Article
Tasquinimod prevents the angiogenic rebound induced by fractionated radiation resulting in an enhanced therapeutic response of prostate cancer xenografts.
- Published in:
- Prostate, 2012, v. 72, n. 6, p. 638, doi. 10.1002/pros.21467
- By:
- Publication type:
- Article
Radiotherapy augments the immune response to prostate cancer in a time-dependent manner.
- Published in:
- Prostate, 2008, v. 68, n. 12, p. 1319, doi. 10.1002/pros.20794
- By:
- Publication type:
- Article
Anti-tumor effect of combination therapy with intratumoral controlled-release paclitaxel (PACLIMER® microspheres) and radiation.
- Published in:
- Prostate, 2004, v. 58, n. 3, p. 291, doi. 10.1002/pros.10331
- By:
- Publication type:
- Article
Feasibility of Ablating Normal Renal Parenchyma by Interstitial Photon Radiation Energy: Study in a Canine Model.
- Published in:
- Journal of Endourology, 2000, v. 14, n. 2, p. 111, doi. 10.1089/end.2000.14.111
- By:
- Publication type:
- Article
EXERCISE DURING PROSTATE CANCER TREATMENT: EFFECTS ON FUNCTIONAL STATUS AND SYMPTOMS.
- Published in:
- Oncology Nursing Forum, 2007, v. 34, n. 1, p. 189
- By:
- Publication type:
- Article
Comparison of Biochemical Recurrence–Free Survival Between Periprostatic and Pelvic Lymph Node Metastases of Prostate Cancer.
- Published in:
- International Journal of Surgical Pathology, 2013, v. 21, n. 4, p. 352, doi. 10.1177/1066896913482729
- By:
- Publication type:
- Article
TP53 structure–function relationships in metastatic castrate‐sensitive prostate cancer and the impact of APR‐246 treatment.
- Published in:
- Prostate, 2024, v. 84, n. 1, p. 87, doi. 10.1002/pros.24629
- By:
- Publication type:
- Article
Cover Image: Volume 83 Issue 3.
- Published in:
- Prostate, 2023, v. 83, n. 3, p. i, doi. 10.1002/pros.24484
- By:
- Publication type:
- Article
The impact of salvage radiotherapy initiation at PSA ≤ 0.5 ng/ml on metastasis‐free survival in patients with relapsed prostate cancer following prostatectomy.
- Published in:
- Prostate, 2023, v. 83, n. 3, p. 190, doi. 10.1002/pros.24452
- By:
- Publication type:
- Article
The impact of salvage radiotherapy initiation at PSA ≤ 0.5 ng/ml on metastasis‐free survival in patients with relapsed prostate cancer following prostatectomy.
- Published in:
- Prostate, 2023, v. 83, n. 2, p. 190, doi. 10.1002/pros.24452
- By:
- Publication type:
- Article
Radiating the prostate bed in relapsed oligometastatic prostate cancer: How comprehensive should we be?
- Published in:
- Prostate, 2022, v. 82, n. 5, p. 551, doi. 10.1002/pros.24301
- By:
- Publication type:
- Article
Longitudinal measurement of subcutaneous and intratibial human prostate cancer xenograft growth and response to ionizing radiation by plasma Alu and LINE‐1 ctDNA: A comparison to standard methods.
- Published in:
- Prostate, 2021, v. 81, n. 11, p. 745, doi. 10.1002/pros.24171
- By:
- Publication type:
- Article
Impact of a Home-Based Walking Intervention on Outcomes of Sleep Quality, Emotional Distress, and Fatigue in Patients Undergoing Treatment for Solid Tumors.
- Published in:
- Oncologist, 2013, v. 18, n. 4, p. 476, doi. 10.1634/theoncologist.2012-0278
- By:
- Publication type:
- Article
Improving providers' survival estimates and selection of prognosis‐ and guidelines‐appropriate treatment for patients with symptomatic bone metastases: Development of the Bone Metastases Ensemble Trees for Survival Decision Support Platform.
- Published in:
- Journal of Evaluation in Clinical Practice, 2022, v. 28, n. 4, p. 581, doi. 10.1111/jep.13652
- By:
- Publication type:
- Article
Development and Screening of a Series of Antibody-Conjugated and Silica-Coated Iron Oxide Nanoparticles for Targeting the Prostate-Specific Membrane Antigen.
- Published in:
- ChemMedChem, 2014, v. 9, n. 7, p. 1356, doi. 10.1002/cmdc.201300549
- By:
- Publication type:
- Article
Long-term effects of androgen deprivation therapy in prostate cancer patients.
- Published in:
- Clinical Endocrinology, 2002, v. 56, n. 6, p. 779, doi. 10.1046/j.1365-2265.2002.01551.x
- By:
- Publication type:
- Article
Targeting of mutant hogg1 in mammalian mitochondria and nucleus: effect on cellular survival upon oxidative stress.
- Published in:
- BMC Cancer, 2006, v. 6, p. 1, doi. 10.1186/1471-2407-6-235
- By:
- Publication type:
- Article